118 related articles for article (PubMed ID: 11788049)
21. [Immunization with recombinant HBcAg and β-amyloid peptide fusion protein promotes clearance of intrahippocampally injected β-amyloid peptide in rats].
Feng GF; Hu HT; Jin H; Wang WX; Qian YH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1236-9. PubMed ID: 21764704
[TBL] [Abstract][Full Text] [Related]
22. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
[TBL] [Abstract][Full Text] [Related]
23. Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1.
Buckwalter MS; Coleman BS; Buttini M; Barbour R; Schenk D; Games D; Seubert P; Wyss-Coray T
J Neurosci; 2006 Nov; 26(44):11437-41. PubMed ID: 17079673
[TBL] [Abstract][Full Text] [Related]
24. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
25. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
Seabrook TJ; Thomas K; Jiang L; Bloom J; Spooner E; Maier M; Bitan G; Lemere CA
Neurobiol Aging; 2007 Jun; 28(6):813-23. PubMed ID: 16725229
[TBL] [Abstract][Full Text] [Related]
26. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
[TBL] [Abstract][Full Text] [Related]
27. Immunization of Tg-APPswe/PSEN1dE9 mice with Aβ3-10-KLH vaccine prevents synaptic deficits of Alzheimer's disease.
Meng Y; Ding L; Zhang H; Yin W; Yan Y; Cao Y
Behav Brain Res; 2017 Aug; 332():64-70. PubMed ID: 28577919
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapeutic efficiency of a tetravalent Aβ1-15 vaccine in APP/PS1 transgenic mice as mouse model for Alzheimer's disease.
Guan X; Yang J; Gu H; Zou J; Yao Z
Hum Vaccin Immunother; 2013 Aug; 9(8):1643-53. PubMed ID: 23732905
[TBL] [Abstract][Full Text] [Related]
29. Aβ measurement by enzyme-linked immunosorbent assay.
Schmidt SD; Mazzella MJ; Nixon RA; Mathews PM
Methods Mol Biol; 2012; 849():507-27. PubMed ID: 22528112
[TBL] [Abstract][Full Text] [Related]
30. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
31. Impairments of long-term depression induction and motor coordination precede Aβ accumulation in the cerebellum of APPswe/PS1dE9 double transgenic mice.
Kuwabara Y; Ishizeki M; Watamura N; Toba J; Yoshii A; Inoue T; Ohshima T
J Neurochem; 2014 Aug; 130(3):432-43. PubMed ID: 24684630
[TBL] [Abstract][Full Text] [Related]
32. Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system.
Vollmar P; Kullmann JS; Thilo B; Claussen MC; Rothhammer V; Jacobi H; Sellner J; Nessler S; Korn T; Hemmer B
J Immunol; 2010 Nov; 185(10):6338-47. PubMed ID: 20943998
[TBL] [Abstract][Full Text] [Related]
33. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
[TBL] [Abstract][Full Text] [Related]
34. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
[TBL] [Abstract][Full Text] [Related]
35. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
[TBL] [Abstract][Full Text] [Related]
36. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
[TBL] [Abstract][Full Text] [Related]
37. Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage.
Nikolic WV; Bai Y; Obregon D; Hou H; Mori T; Zeng J; Ehrhart J; Shytle RD; Giunta B; Morgan D; Town T; Tan J
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2507-12. PubMed ID: 17264212
[TBL] [Abstract][Full Text] [Related]
38. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease.
Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT
Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267
[TBL] [Abstract][Full Text] [Related]
39. Abeta1-15 is less immunogenic than Abeta1-40/42 for intranasal immunization of wild-type mice but may be effective for "boosting".
Leverone JF; Spooner ET; Lehman HK; Clements JD; Lemere CA
Vaccine; 2003 May; 21(17-18):2197-206. PubMed ID: 12706711
[TBL] [Abstract][Full Text] [Related]
40. Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology.
Nemirovsky A; Shapiro J; Baron R; Kompaniets A; Monsonego A
J Neuroimmunol; 2012 Jun; 247(1-2):95-9. PubMed ID: 22498096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
